Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Find out more about the MS-UK Helpline

Find out more about our Choices booklets

Find out more about New Pathways magazine

 


Healthcare Improvement Scotland has published revised standards to help health and social care professionals improve the care and support provided for the estimated one million adults in Scotland...
Inflammation and demyelination are the main processes in multiple sclerosis (MS). However, to date, blood biomarkers of inflammation are lacking. TWEAK, a transmembrane protein that belongs to the...
Some studies have suggested that minerals such as zinc and iron may play a role in how multiple sclerosis (MS) progresses after diagnosis, but little was known about whether zinc, iron and other...
The US Food and Drug Administration has approved siponimod (Mayzent) tablets to treat adults with relapsing forms of multiple sclerosis (MS), which will include clinically isolated syndrome,...
Brain stem cells in people with the more advanced forms of multiple sclerosis (MS) look much older than they really are, according to a study led by UConn Health and published in the Proceedings of...
Some studies have suggested that people who are younger when they enter puberty are more likely to later develop multiple sclerosis (MS). But a new study, published in the online issue of Neurology,...
After following nearly 6,000 patients for more than two decades researchers from the University of British Columbia and Vancouver Coastal Health Research Institute have found that a widely prescribed...
GeNeuro, a biopharmaceutical company developing new treatments for neurodegenerative and autoimmune diseases such as multiple sclerosis (MS), has announced positive results from the ANGEL-MS study of...
Cleveland Clinic Lou Ruvo Center for Brain Health in the US is now recruiting participants for a new, relapsing remitting multiple sclerosis (RRMS) treatment trial, DELIVER-MS. Cleveland Clinic will...
It was announced yesterday at the Novel Food Commission meeting in Brussels that the European Food Safety Association (EFSA) is reviewing its decision to classify CBD as a novel food. It is thought...

Pages